| ²é¿´: 720 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
wchuangqiͳæ (СÓÐÃûÆø)
|
[½»Á÷]
ʲô½Ð¹¦ÄÜ»ñµÃÐÔÍ»±ä£¿Çë¸÷λ´óÏÀ°ï棡
|
||
| ½ñÈÕ¿´µ½Ò»¶Î¹ØÓÚÒÒÏ©ÊÜÌåµÄÃèÊö£¬ÈçÏ£º·Ö×ÓÒÅ´«Ñ§µÄÑо¿·¢ÏÖ£¬5¸öÊÜÌ壨ETR1,ETR2,ERS1,ERS2ºÍEIN4£©ÖеÄÈÎÒâÒ»¸ö·¢Éú¹¦ÄÜ»ñµÃÐÔÍ»±ä¶¼µ¼ÖÂÒÒÏ©²»Ãô¸Ð¡£ÇëÎÊÕâÀïµÄ¹¦ÄÜ»ñµÃÐÔÍ»±äʱʲôÒâ˼£¿Ê²Ã´½Ð¹¦ÄÜ»ñµÃÐÔÍ»±ä£¿ËüÓм¸²ãº¬Ò壿ллÀ²£¡Ð¡µÜ³õÀ´Õ§µ½£¬Ï£Íû´ó¼Ò°ïæ¡£ |
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ15È˻ظ´
ÕÐ08¿¼Êýѧ
ÒѾÓÐ16È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏר˶ÕÒµ÷¼Á
ÒѾÓÐ4È˻ظ´
0854µç×ÓÐÅÏ¢Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
0805 316Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0854 ¿¼Ñе÷¼Á ÕÐÉúÁË£¡AI ·½Ïò
ÒѾÓÐ17È˻ظ´
¡¾¿¼Ñе÷¼Á¡¿»¯Ñ§×¨Òµ 281·Ö£¬Ò»Ö¾Ô¸ËÄ´¨´óѧ£¬³ÏÐÄÇóµ÷¼Á
ÒѾÓÐ15È˻ظ´
×ÊÔ´Óë»·¾³ µ÷¼ÁÉêÇë(333·Ö)
ÒѾÓÐ7È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

sutao1979
ľ³æ (ÖøÃûдÊÖ)
Сľ³æ10Äêgroupleader
- BioEPI: 1
- Ó¦Öú: 5 (Ó×¶ùÔ°)
- ¹ó±ö: 0.694
- ½ð±Ò: 3553.3
- É¢½ð: 150
- ºì»¨: 3
- Ìû×Ó: 1479
- ÔÚÏß: 64Сʱ
- ³æºÅ: 79951
- ×¢²á: 2005-07-12
- ÐÔ±ð: GG
- רҵ: Ö²Îï·ÖÀàѧ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
|
Gain-of-function mutations :change the gene product such that it gains a new and abnormal function. These mutations usually have dominant phenotypes. Often called a neomorphic mutation ÒÔÉÏÊÇÕýÈ·µÄ½âÊÍ |

2Â¥2009-08-27 22:34:40
wchuangqi
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 30 (СѧÉú)
- ½ð±Ò: 79.8
- ºì»¨: 1
- Ìû×Ó: 139
- ÔÚÏß: 143.4Сʱ
- ³æºÅ: 827947
- ×¢²á: 2009-08-14
- ÐÔ±ð: GG
- רҵ: Ö²ÎïÉúÀíÓëÉú»¯

3Â¥2009-09-01 20:08:13













»Ø¸´´ËÂ¥